Host factors play an important role in determining rates of disease pr
ogression in human immunodeficiency virus (HIV)-infected individuals.
HIV is able to subvert the host immune system by infecting CD4(+) T ce
lls that normally orchestrate immune responses and by inducing the sec
retion of proinflammatory cytokines that the virus can utilize to its
own replicative advantage. The recognition that certain chemokine rece
ptors serve as necessary co-factors for MV entry into its target cells
as well as the fact that ligands for these receptors can modulate the
efficiency of HN infection has expanded the number and scope of host
factors that may impact the pathogenesis of HIV disease. This area of
investigation will no doubt yield novel therapeutic strategies for int
ervention in HIV disease; however, caution is warranted in light of th
e enormous complexity of the pleiotropic cytokine and chemokine networ
ks and the uncertainty inherent in manipulating these systems. HIV-inf
ected long-term non-progressors represent an excellent model to study
potential host factors involved in HN disease pathogenesis. Genetic fa
ctors certainly have a major impact on the immune responses mounted by
the host. In this regard, a polymorphism in the gene for the HIV co-r
eceptor CC chemokine receptor 5 (CCR5), which serves as a coreceptor f
or macrophage (M)-tropic strains of HIV, affords a high degree of prot
ection against HIV infection in individuals homozygous for the genetic
defect and some degree of protection against disease progression in H
IV-infected heterozygotes. HIV-specific immune responses, including cy
totoxic T-lymphocyte (CTL) responses and neutralizing antibody respons
es, also appear to play salutary roles in protecting against disease p
rogression.